When was Liminatus Pharma, Inc. Class A Common Stock stock made available for the first time to the public?

The IPO Date for Liminatus Pharma, Inc. Class A Common Stock is 2025-05-01. On this 2025-05-01, Liminatus Pharma, Inc. Class A Common Stock stock was made publicly available.

Where is the headquarters of Liminatus Pharma, Inc. Class A Common Stock stock?

Headquarters information for Liminatus Pharma, Inc. Class A Common Stock is currently unavailable. We'll update this as soon as it's available.

What industry does Liminatus Pharma, Inc. Class A Common Stock belong to?

The Liminatus Pharma, Inc. Class A Common Stock belongs to Biotechnology.

Liminatus Pharma, Inc. Class A Common Stock

LIMN•NASDAQ

Healthcare

Biotechnology

$16.25

$-7.73(-32.24%)

Liminatus Pharma, Inc. Class A Common Stock (LIMN) Company Profile & Overview

Explore Liminatus Pharma, Inc. Class A Common Stock’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Liminatus Pharma, Inc. Class A Common Stock (LIMN) Company Profile & Overview

Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.

SectorHealthcare

IndustryBiotechnology

CEOMr. Chris Kim J.D., L.L.M.

Contact Information

https://liminatuspharma.com

6 Centerpointe Drive, La Palma

Company Facts

3 Employees

IPO DateMay 1, 2025

CountryUS

Actively Trading

Frequently Asked Questions

;